company

NOVELAKLINIKKEN KRISTIANSAND AS

4612 KRISTIANSAND S

Return on Equity
25,89 %
Current Ratio
0,56
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue4 736 000
Net Income58 000
Total Assets1 151 000
Total Equity224 000
Income (NOK)2022
Revenue4 736 000
Expenditure4 740 000
Operating Profit79 000
Financial Income0
Financial Costs5 000
Financial Balance−5 000
Earnings Before Tax74 000
Tax16 000
Net Income58 000
Balance (NOK)2022
Total Fixed Assets630 000
Total Current Assets522 000
Total Assets1 151 000
Total Retained Equity23 000
Total Equity224 000
Total Long-Term Debt0
Total Current Debt927 000
Total Equity and Debt1 151 000
Cash flow (NOK)2022
Sales Income4 736 000
Other Income0
Revenue4 736 000
Cost of Goods Sold1 842 000
Salary Costs1 624 000
Depreciation108 000
Impairment0
Expenditure4 740 000
Operating Profit79 000
Financial Income0
Financial Costs5 000
Financial Balance−5 000
Dividends0
Net Income58 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets52 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures16 000
Total Tangible Assets16 000
Total Fiancial Fixed Assets562 000
Total Fixed Assets630 000
Stock219 000
Total Investments0
Cash, Bank288 000
Total Current Assets522 000
Total Assets1 151 000
Total Equity224 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors60 000
Unpaid Taxes158 000
Dividends0
Other Current Debt709 000
Total Current Debt927 000
Total Equity and Debt1 151 000
Financial indicators2022
Return on Equity25,89 %
Debt-to-Equity Ratio0
Operating Profit Margin1,67 %
Current Ratio0,56
Quick Ratio0,74
Equity Ratio0,19
Gross Profit Margin61,11 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English